Loading...
XSHE
002393
Market cap740mUSD
Dec 05, Last price  
20.43CNY
1D
0.49%
1Q
-17.42%
Jan 2017
-50.53%
IPO
-64.03%
Name

Tianjin Lisheng Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002393 chart
P/E
28.36
P/S
3.92
EPS
0.72
Div Yield, %
4.11%
Shrs. gr., 5y
7.03%
Rev. gr., 5y
-3.72%
Revenues
1.34b
+15.88%
349,443,082393,291,513592,538,348595,702,228737,972,252763,641,6071,117,067,9151,044,397,823773,725,673774,782,192846,853,2231,029,433,4311,503,607,4071,615,276,3731,140,837,5551,091,940,6311,146,589,3841,153,032,8011,336,154,449
Net income
185m
-49.00%
100,226,256132,447,588132,007,538154,507,713203,395,229324,769,164297,105,384298,058,98592,883,574114,214,489115,606,305116,817,244184,977,556188,137,4018,615,268122,105,33693,606,639361,827,990184,528,445
CFO
88m
-57.87%
0174,942,818126,586,709196,142,549186,551,923134,583,458250,722,782289,615,40572,238,880198,128,640173,596,260179,246,598162,686,709268,326,34676,370,096196,336,646331,381,244209,507,39488,263,356
Dividend
May 28, 20240.84 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the production and sale of chemical medicines. The company offers tablets, hard capsules, dripping pills, freeze-dried powder injections, water injections, and bulk medicines, as well as intermediates, diagnostic reagents, biochemical reagents, and plastic bottles. It also exports its products. The company is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.
IPO date
Apr 23, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT